Suraksha Diagnostic LtdHealthcare Service ProviderINE877V01027Consolidated₹336.05+6.50 (+1.97%)Jun-26
Valuation
Market Cap₹1.75K Cr
TTM PE48.71x
Forward PE48.80x
PEG4.30
Book Value₹47.01
P/B7.13x
TTM EPS₹6.88
Fwd EPS₹6.87
TTM Revenue₹325.48 Cr
TTM PAT₹35.08 Cr
TTM EBITDA₹102.10 Cr
TTM EBIT₹58.85 Cr
Last Qtr PAT₹12.85 Cr
Last Qtr EBITDA₹30.44 Cr
Last Qtr EBIT₹19.16 Cr
Profitability
ROE14.33%
ROCE16.58%
TTM NPM10.78%
TTM EBITDA %31.37%
Curr OPM14.48%
Last OPM7.49%
Curr NPM
Last NPM
Curr EPS₹2.50
Last EPS₹1.21
Balance sheet
Equity₹10.42 Cr
Reserve₹234.43 Cr
Total Debt₹130.34 Cr
D/E0.53x
Interest %28.95%
Curr Interest₹3.72 Cr
Price / range
Close₹335.10
vs 52W High
vs 52W Low
MA50
MA200
Returns
1D+1.87%
1W+3.70%
1M+5.86%
3M+28.41%
6M+28.61%
1Y+5.00%
2Y
3Y
5Y
Diwali+22.72%
Sector peers — Healthcare Service Provider
CompanyCloseMkt CapTTM P/EROE
LALPATHLAB1896.90₹31.80K Cr58.4621.78%
VIJAYA1558.90₹16.04K Cr85.5119.59%
METROPOLIS597.45₹12.39K Cr61.4013.40%
THYROCARE555.80₹8.85K Cr50.3930.04%
NEPHROPLUS743.35₹7.46K Cr87.666.88%
KRSNAA541.15₹1.76K Cr18.009.94%
SURAKSHA335.10₹1.75K Cr48.7114.33%
3BBLACKBIO1326.95₹1.14K Cr19.5621.67%

Financial Results

Quarterly and yearly P&L · YoY % on Revenue, Total Income, Expenditure, EBITDA, EBIT, PBT, Net Profit and EPS

Standalone

16 lines · 6 periods
MetricJun-26Mar-26Dec-25Sep-25Jun-25FY25-26
Revenue84.09+19.6%78.5675.5876.2670.28300.68
Other Income1.561.300.990.971.104.35
Total Income85.65+20.0%79.8676.5777.2371.37305.03
Interest3.673.873.102.722.6612.34
Expenditure-69.44-19.2%-69.30-65.60-64.66-58.25-257.82
PBDT000000
EBITDA28.92+21.3%23.8223.1923.9723.8494.80
Depreciation-10.60-10.69-10.11-9.65-9.15-39.60
EBIT18.32+24.7%13.1313.0814.3214.6955.20
PBT16.21+23.6%10.5610.9712.5713.1247.22
Tax-3.63-3.85-2.83-3.21-3.27-13.15
Equity10.4210.420010.4210.42
OPM18.9313.2214.5116.4818.3815.48
Net Profit12.58+27.7%6.718.149.369.8534.06
NPM14.698.4010.7712.2813.8011.17
EPS2.42+28.0%1.291.561.801.896.54

Yearly results

Last 6 financial years · YoY % vs previous FY

Yearly

17 lines · 2 years
MetricFY 25-26FY 24-25
Revenue300.68+20.7%249.10
Other Income4.354.38
Total Income305.03+20.3%253.48
Expenditure-257.82-23.0%-209.62
Interest-12.34-8.39
PBDT00
EBITDA94.80+14.8%82.60
Depreciation-39.60-34.73
EBIT55.20+15.3%47.87
PBT47.22+7.7%43.86
Tax-13.15-10.42
Equity10.4210.42
OPM (%)15.4817.30
Net Profit34.06+1.9%33.44
NPM (%)11.1713.19
EPS (Rs)6.54+1.9%6.42
CEPS6.546.42

Consolidated

16 lines · 6 periods
MetricJun-26Mar-26Dec-25Sep-25Jun-25FY25-26
Revenue87.65+20.7%81.4177.6978.7372.59310.41
Other Income1.090.790.620.850.913.16
Total Income88.73+20.7%82.2078.3179.5873.49313.58
Interest3.723.923.162.782.7012.55
Expenditure-72.21-18.3%-72.22-68.25-67.53-61.02-269.02
PBDT000000
EBITDA30.44+28.2%24.3723.1724.1223.7595.39
Depreciation-11.28-11.26-10.57-10.14-9.48-41.45
EBIT19.16+34.3%13.1112.6013.9814.2753.94
PBT16.53+32.6%9.9810.0612.0512.4744.56
Tax-3.68-3.82-2.82-3.22-3.29-13.15
Equity10.4210.420010.4210.42
OPM18.6312.1412.8515.1416.9714.21
Net Profit12.85+40.0%6.167.248.839.1831.40
NPM14.487.499.2511.0912.4910.01
EPS2.50+38.9%1.211.441.731.806.18

Yearly results

Last 6 financial years · YoY % vs previous FY

Yearly

17 lines · 2 years
MetricFY 25-26FY 24-25
Revenue310.41+23.1%252.09
Other Income3.163.85
Total Income313.58+22.5%255.94
Expenditure-269.02-25.4%-214.53
Interest-12.55-8.39
PBDT00
EBITDA95.39+17.4%81.25
Depreciation-41.45-35.30
EBIT53.94+17.4%45.95
PBT44.56+7.6%41.41
Tax-13.15-10.43
Equity10.4210.42
OPM (%)14.2116.18
Net Profit31.40+1.4%30.98
NPM (%)10.0112.10
EPS (Rs)6.18+3.5%5.97
CEPS6.185.97

Corporate Actions

Dividends, bonus issues, and stock splits

Dividend

2
YearTypeAmountEx-Date
2026Final Dividend0.515 Sep 2026
2026Final Dividend0.525 Aug 2026

Bonus

0

No bonus history.

Split

0

No split history.

Loading company dashboard...
Fetching ratios, charts, and peers